Efficacy of bactericidal/permeability-increasing protein in experimental otitis media with effusion in rats: A new therapy for mucosal infections

• Published in: The Journal of laboratory and clinical medicine Vol. 137; no. 4; pp. 303 - 309
• Main Authors: Nell, Marja J., Grote, Jan J.
• Format: Journal Article
• Language: English
• Published: Saint Louis, MO Mosby, Inc 01-04-2001; Elsevier
• Subjects: Animals; Antimicrobial Cationic Peptides; Biological and medical sciences; Blood Proteins - therapeutic use; Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology; Female; Medical sciences; Membrane Proteins; Microscopy, Electron, Scanning; Mucous Membrane - pathology; Mucous Membrane - ultrastructure; Non tumoral diseases; Otitis Media with Effusion - drug therapy; Otorhinolaryngology. Stomatology; Rats; Rats, Wistar; ETO; LM; OME; BPI; GNB; SEM; MCS; LPS; ET; Effusion; Rat; Middle ear disease; Treatment efficiency; Rodentia; Permeability; Bactericidal effect; Binding protein; Vertebrata; Mammalia; Animal; Lipopolysaccharide; ENT disease; Otitis media
• ISSN: 0022-2143; 1532-6543
• DOI: 10.1067/mlc.2001.113371

Otitis media with effusion (OME) is characterized by the presence of fluid in the middle ear without signs or symptoms of acute infection and by persistent changes in the middle ear mucosa. These are mainly induced by gram-negative bacterial infection and dysfunction of the eustachian tube (ET). Gram-negative bacteria (GNB) contain lipopolysaccharide (LPS) in their outer membrane that is responsible for inflammatory reactions in the middle ear. In this study we investigated the therapeutic effect of a recombinant LPS-binding protein, bactericidal/permeability-increasing protein (rBPI21), on the repair of mucosal damage in rats with experimentally induced OME. OME was induced by obstruction of the eustachian tube in combination with LPS injection. Twelve weeks after OME induction, secretory cells in the tympanic orifice of the middle ear were increased from an average of 14 ± 2 to 31 ± 5, ciliated cells were decreased from 24 ± 4 to 6 ± 4, and the number of macrophages in the subepithelial layer increased from 13 ± 4 to 27 ± 3. A single dose of rBPI21 was administered directly into the middle ear cavity 2 weeks after the induction of OME. Histologic examination of the middle ear mucosa at 4 and 12 weeks after OME induction showed that mucosal changes were restored by rBPI21 treatment. These results demonstrate that the middle ear mucosa recovers from inflammatory changes associated with OME after treatment with rBPI21. This suggests that rBPI21 may be useful in the treatment of OME and of mucosal infections of the respiratory tract. (J Lab Clin Med 2001;137:303-9)